Actionable news
All posts from Actionable news
Actionable news in EXAS: EXACT Sciences Corporation,

Exact Sciences: Lifting Sales Estimates

Exact Sciences (EXAS) is trading higher Friday, thanks to a bullish note from Benchmark.

Analyst Raymond Myers reiterated a Buy rating and $50 price target on the stock, as he’s also raising his estimates to account for more rapidly expanding managed care contracting.

More detail from his note:

We have confirmed...